Cargando…
What does the anesthesiologist need to know about monkeypox?
PURPOSE: Monkeypox (or “mpox” as preferred by the World Health Organization) is an emerging infectious disease with sustained global transmission occurring outside of West Africa and the Democratic Republic of Congo. The recent 2022 mpox outbreak has involved widespread atypical presentations. Infec...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005856/ https://www.ncbi.nlm.nih.gov/pubmed/36899136 http://dx.doi.org/10.1007/s12630-023-02441-2 |
_version_ | 1784905179463680000 |
---|---|
author | Teo, Chao Tong Wu, Jiawei Sean Chan, Karen Ng, Su Wei Bryan Somani, Jyoti Loh, Will |
author_facet | Teo, Chao Tong Wu, Jiawei Sean Chan, Karen Ng, Su Wei Bryan Somani, Jyoti Loh, Will |
author_sort | Teo, Chao Tong |
collection | PubMed |
description | PURPOSE: Monkeypox (or “mpox” as preferred by the World Health Organization) is an emerging infectious disease with sustained global transmission occurring outside of West Africa and the Democratic Republic of Congo. The recent 2022 mpox outbreak has involved widespread atypical presentations. Infected patients requiring surgery can increase the exposure of health care professionals and other patients to the virus. As it is a relatively new infectious disease internationally, there is less familiarity in managing this risk, especially in the surgical and anesthesia setting. This paper aims to provide information about mpox and how to manage suspected or confirmed cases. SOURCE: Various authorities such as the World Health Organization, Infection Prevention and Control Canada, Public Health Agency of Canada, the Centers for Disease Control and Prevention (USA), and the National Centre for Infectious Diseases (Singapore) have recommended that public health and hospital systems prepare to recognize, isolate, and care for suspected and confirmed cases appropriately, as well as manage any possible exposure of staff and patients. PRINCIPAL FINDINGS: Local authorities and hospitals should set up protocols for health care providers (HCPs) to minimize nosocomial transmission and risk to HCPs. Antivirals used in patients with more severe disease may cause renal or hepatic impairment and thus anesthetic drug pharmacology. Anesthesiologists and surgeons should be able to recognize mpox, and work with local infection control and epidemiologic programs to familiarize themselves with relevant infection prevention guidelines. CONCLUSION: Essential measures include clear protocols for transferring and managing surgical patients who are suspected or confirmed to be infected with the virus. Care in use of personal protective equipment and handling contaminated material is necessary to prevent inadvertent exposure. Risk stratification after exposure should be done to determine need for post-exposure prophylaxis for staff. |
format | Online Article Text |
id | pubmed-10005856 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-100058562023-03-13 What does the anesthesiologist need to know about monkeypox? Teo, Chao Tong Wu, Jiawei Sean Chan, Karen Ng, Su Wei Bryan Somani, Jyoti Loh, Will Can J Anaesth Review Article/Brief Review PURPOSE: Monkeypox (or “mpox” as preferred by the World Health Organization) is an emerging infectious disease with sustained global transmission occurring outside of West Africa and the Democratic Republic of Congo. The recent 2022 mpox outbreak has involved widespread atypical presentations. Infected patients requiring surgery can increase the exposure of health care professionals and other patients to the virus. As it is a relatively new infectious disease internationally, there is less familiarity in managing this risk, especially in the surgical and anesthesia setting. This paper aims to provide information about mpox and how to manage suspected or confirmed cases. SOURCE: Various authorities such as the World Health Organization, Infection Prevention and Control Canada, Public Health Agency of Canada, the Centers for Disease Control and Prevention (USA), and the National Centre for Infectious Diseases (Singapore) have recommended that public health and hospital systems prepare to recognize, isolate, and care for suspected and confirmed cases appropriately, as well as manage any possible exposure of staff and patients. PRINCIPAL FINDINGS: Local authorities and hospitals should set up protocols for health care providers (HCPs) to minimize nosocomial transmission and risk to HCPs. Antivirals used in patients with more severe disease may cause renal or hepatic impairment and thus anesthetic drug pharmacology. Anesthesiologists and surgeons should be able to recognize mpox, and work with local infection control and epidemiologic programs to familiarize themselves with relevant infection prevention guidelines. CONCLUSION: Essential measures include clear protocols for transferring and managing surgical patients who are suspected or confirmed to be infected with the virus. Care in use of personal protective equipment and handling contaminated material is necessary to prevent inadvertent exposure. Risk stratification after exposure should be done to determine need for post-exposure prophylaxis for staff. Springer International Publishing 2023-03-10 2023 /pmc/articles/PMC10005856/ /pubmed/36899136 http://dx.doi.org/10.1007/s12630-023-02441-2 Text en © Canadian Anesthesiologists' Society 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Article/Brief Review Teo, Chao Tong Wu, Jiawei Sean Chan, Karen Ng, Su Wei Bryan Somani, Jyoti Loh, Will What does the anesthesiologist need to know about monkeypox? |
title | What does the anesthesiologist need to know about monkeypox? |
title_full | What does the anesthesiologist need to know about monkeypox? |
title_fullStr | What does the anesthesiologist need to know about monkeypox? |
title_full_unstemmed | What does the anesthesiologist need to know about monkeypox? |
title_short | What does the anesthesiologist need to know about monkeypox? |
title_sort | what does the anesthesiologist need to know about monkeypox? |
topic | Review Article/Brief Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005856/ https://www.ncbi.nlm.nih.gov/pubmed/36899136 http://dx.doi.org/10.1007/s12630-023-02441-2 |
work_keys_str_mv | AT teochaotong whatdoestheanesthesiologistneedtoknowaboutmonkeypox AT wujiaweisean whatdoestheanesthesiologistneedtoknowaboutmonkeypox AT chankaren whatdoestheanesthesiologistneedtoknowaboutmonkeypox AT ngsuweibryan whatdoestheanesthesiologistneedtoknowaboutmonkeypox AT somanijyoti whatdoestheanesthesiologistneedtoknowaboutmonkeypox AT lohwill whatdoestheanesthesiologistneedtoknowaboutmonkeypox |